Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

Jun 01, 2024 08:00 ET
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced data from an ongoing Phase 1 study of AC699 monotherapy in patients with ER-positive / HER2-negative locally advanced or metastatic breast cancer. The data will be presented in a poster discussion session at ...
Jun 01, 2024 08:00 ET
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced longer-term efficacy and safety results from Arm A1 of the Phase 2 EDGE-Gastric study. These updated data show consistent objective response rate (ORR) and provide mature progression-free survival (PFS) in patients with locally advanced unresectable or metastatic gastric, gastroesophageal junction or esophageal adenocarcinoma (upper GI cancers). The ongoing, multi-arm, global Phase 2 EDGE-Gastric study is evaluating the safety and efficacy of various combinations of the Fc-silent anti-TIGIT antibody d...
Jun 01, 2024 08:00 ET
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) announced that the Journal of the American Medical Association (JAMA) published a manuscript titled, “Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer with EGFR Variant: A Randomized Clinical Trial.” The publication is based on the results of HARMONi-A, a single region, multi-center, Phase III study conducted in China sponsored by Akeso, Inc. (Akeso, HKEX Code: 9926.HK), with data generated and analyzed by Akeso....
Jun 01, 2024 08:00 ET
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Canc
Bristol Myers Squibb (NYSE: BMY) today announced results from the Phase 3 KRYSTAL-12 study evaluating KRAZATI® (adagrasib) compared to standard of care chemotherapy in patients with locally advanced or metastatic KRASG12C-mutated non-small cell lung cancer (NSCLC) who had previously received platinum-based chem...
Jun 01, 2024 08:00 ET
Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
ASCO Annual Meeting – Massive Bio, pioneering leader in AI-driven oncology solutions, is excited to announce the launch of its latest product, Drug Utilization Optimizer (DUO), at the upcoming ASCO Annual Meeting 2024. The innovative analytics and real-time notification platform is designed to revolutionize how pharmaceutical commercial teams tar...
Jun 01, 2024 08:00 ET
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Pfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 3 ECHELON-3 study of ADCETRIS® (brentuximab vedotin) in combination with lenalidomide and rituximab for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). The study showed that the ADCETRIS combination reduced patients’ risk of death by 37% compared to placebo in combination with lenalidomide and rituximab (HR 0.63 [95% CI: 0.445-0.891] p=0.0085). The overall survival benefit was consistent across levels of CD30 expression....
May 31, 2024 22:02 ET
The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought
As a result of the severe drought impacting much of Mexico, The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company, today announced it is complying with a request from the government to temporarily minimize water intake, which has led to a pause in production at its Altamira Titanium Dioxide (TiO2) manufacturing facility to conserve water for the surrounding communities....
May 31, 2024 19:43 ET
Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is proud to present groundbreaking research on radiogenomics and homologous recombination deficiency (HRD) in breast cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting....
May 31, 2024 18:00 ET
Capstone Copper Announces Retirement of Robert Gallagher from the Board of Directors
Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announces that Mr. Robert (“Bob”) Gallagher has retired from the Board of Directors of the Company effective May 30, 2024....
May 31, 2024 17:49 ET
Fonon's Additive Manufacturing Technology To Transform Construction Industry
Fonon Corporation, a multi-market holding company, R&D center, equipment designer and manufacturer of advanced laser material processing systems for subtractive and additive manufacturing, highlights applications for its Bulk-To-Shape (BTS) additive manufacturing/ 3D metal printing technology for the construction industry. This BTS technology is currently...
May 31, 2024 17:38 ET
Ventas to Present at Nareit’s REITweek 2024 Investor Conference
Ventas, Inc. (NYSE: VTR) (the “Company”) announced today that management will make a presentation regarding the Company at Nareit’s REITweek 2024 Investor Conference (the “Nareit Conference”) on June 4, 2024 at 2:15 p.m. Eastern Time. The webcast will be accessible on the Company’s website at ir.ve...
May 31, 2024 17:35 ET
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against NWTN Inc. (NWTN)
The law firm of Kirby McInerney LLP is investigating potential claims against NWTN Inc. (“NWTN” or the “Company”) (NASDAQ: NWTN). The investigation concerns whether NWTN and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices....
May 31, 2024 16:35 ET
State Street Corporation (NYSE: STT) Announces Date for Release of Second-Quarter 2024 Financial Results and Conference Call Webcast
State Street Corporation (NYSE: STT) plans to announce its second-quarter 2024 financial results on Tuesday, July 16, 2024 at approximately 7:30 a.m. ET. A conference call to review the firm’s financial results will be held at 11:00 a.m. ET....
May 31, 2024 16:15 ET
Camden Property Trust Announces Participation in Nareit’s REITweek 2024 Investor Conference and Provides Second Quarter 2024 Operating Update
Camden Property Trust (NYSE: CPT) (the “Company”) announced today that it will participate in Nareit’s REITweek 2024 Investor Conference which is being held June 3-6, 2024....
May 31, 2024 16:15 ET
Emerald to Participate in Maxim Group TMT Conference
Emerald Holding, Inc. (NYSE: EEX) (“Emerald” or the “Company”), America’s largest producer of trade shows and their associated conferences, content and commerce, today announced that the Company is scheduled to participate virtually in Maxim Group’s conference titled “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era.”...
May 31, 2024 16:15 ET
Pacific Coast Oil Trust Announces There Will Be No May Cash Distribution
PACIFIC COAST OIL TRUST (OTC–ROYTL) (the “Trust”), a royalty trust formed by Pacific Coast Energy Company LP (“PCEC”), announced today that there will be no cash distribution to the holders of its units of beneficial interest of record on May 31, 2024 based on the Trust’s calculation of net profits generated during March 2024 (the “Current Month”) as provided in the conveyance of net profits interests and overriding royalty interest (the “Conveyance”). As further described below under “Update on Estimated Asset Retirement Obligations,” based on information from PCEC, any monthly payments that ...
May 31, 2024 16:05 ET
Bruker Corporation to Present at Upcoming Investor Conferences
Bruker Corporation (Nasdaq: BRKR) announced today it will present at the following conferences:...
May 31, 2024 16:05 ET
Fastly, Inc. Investor Notice: Robbins LLP Reminds Stockholders that a Class Action was Filed Against FSLY
Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Fastly, Inc. (NYSE: FSLY) securities between February 15, 2024 and May 1, 2024. Fastly operates an edge cloud platform for processing, serving, and securing customer’s applications....
May 31, 2024 16:00 ET
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions
The Eaton Vance closed-end funds listed below released today the estimated sources of their May distributions (each a “Fund”). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the May ...